
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma
Xiao‐Han Zhao, Hongmei Gao, Jingyuan Wen, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Xiao‐Han Zhao, Hongmei Gao, Jingyuan Wen, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Showing 4 citing articles:
Current Trends and Innovative Approaches in Cancer Immunotherapy
Jae-Chang Kim, Ruby Maharjan, Jonghyuck Park
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 4
Jae-Chang Kim, Ruby Maharjan, Jonghyuck Park
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 4
Palliative external beam radiotherapy for dysphagia management in advanced esophageal cancer: a narrative perspective
Atsuto Katano
ONCOLOGIE (2025)
Closed Access
Atsuto Katano
ONCOLOGIE (2025)
Closed Access
Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching Analysis
Biqi Chen, Wenyan Chen, Qi Cheng, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 120, Iss. 4, pp. 1084-1095
Closed Access | Times Cited: 3
Biqi Chen, Wenyan Chen, Qi Cheng, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 120, Iss. 4, pp. 1084-1095
Closed Access | Times Cited: 3
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study
Lin Yu, Wenbin Shen, Jinjun Ye, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Lin Yu, Wenbin Shen, Jinjun Ye, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access